AbCellera Biologics Inc

NASDAQ:ABCL   3:59:54 PM EDT
14.81
+0.23 (+1.58%)
: $14.90 +0.09 (+0.61%)
Earnings Announcements

Abcellera Biologics Reports Q3 Loss Per Share $0.08

Published: 11/09/2021 22:42 GMT
AbCellera Biologics Inc (ABCL) - Abcellera Reports Q3 2021 Business Results.
Q3 Loss per Share $0.08.
Q3 Revenue $6.0 Million Versus $9.0 Million.
Revenue is expected to be $123.1 Million
Adjusted EPS is expected to be $0.20

Next Quarter Revenue Guidance is expected to be $76.9 Million
Next Quarter EPS Guidance is expected to be $0.09

More details on our Analysts Page.